MapLight Therapeutics prices USD 150 million PIPE at USD 11.38 a share

Reuters2026/08/13 13:10

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

MapLight Therapeutics priced a USD 150 million PIPE of unregistered equity securities, led by new and existing institutional investors.
Sale covers 9,197,887 common shares at USD 11.38, with pre-funded warrants for up to 3,983,168 shares at USD 11.38.
Pre-funded warrants carry a USD 0.0001 exercise price, are immediately exercisable, do not expire.
Closing expected Aug. 14, 2026, subject to customary conditions; resale registration statement to be filed with the SEC.
Proceeds earmarked for ML-007C-MA development, with cash runway projected through 2028 including PIPE net proceeds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608130910PRIMZONEFULLFEED9809532) on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

MapLight Therapeutics prices USD 150 million PIPE at USD 11.38 a share

You may also like

Crypto prices